Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 12, 2025FARMAKOEKONOMIKA Modern Pharmacoeconomics and PharmacoepidemiologyOpen Access

Chemoproteomic analysis of tenoxicam compared with other nonsteroidal anti-inflammatory drugs

View Full Paper
Ask AI
Bookmark
Share

Authors

ОГО. А. ГромоваITI. Yu. TorshinАГА. Н. Громов

Discussion

Loading...

Member takes

Overview

Chemoproteomic assessment reveals tenoxicam's efficacy-safety balance compared to traditional NSAIDs, suggesting potential benefits.

Key Points

  • Tenoxicam shows improved efficacy-safety balance compared to other NSAIDs, indicating better therapeutic potential.
  • In silico analysis of tenoxicam revealed comparability in anti-inflammatory and analgesic effects with other NSAIDs.
  • Pharmacoinformatic profiling highlighted less micronutrient loss with tenoxicam, differentiating it from traditional anti-inflammatory options.
  • Frequency analysis demonstrated that tenoxicam has the lowest side effect occurrence at 3%, compared to 4-7% for others.

Cite This Study

Громова et al. (2025) studied this question.

synapsesocial.com/papers/68d44a4031b076d99fa53846https://doi.org/10.17749/2070-4909/farmakoekonomika.2025.307
View Full Paper
Ask AI
Bookmark
Share